UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): ~~March~~April 1510, 2012

China Printing & Packaging, Inc.

(Exact Name of Registrant as Specified in Charter)

Nevada	001-34386	35-2298521
(State or Other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)

Xiandong Road, Shangsong Village, Baoji City, Fufeng County

Shaanxi Province, The People's Republic of China 722205

(Address of Principal Executive Offices)

Registrant’s Telephone Number, Including Area Code: 011-86-090-7547-1054

(Former Name or Former Address, if Changed Since Last Report)

Copies To:

Marc Ross, Esq.

Sichenzia Ross Friedman Ference LLP

61 Broadway, 3nd Floor

New York, New York, 10006

Phone: (212) 930-9700

Facsimile: (212) 930-9725

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

Item 41.0201 ~~Non-Reliance~~Entry oninto ~~Previously Issued Financial Statements or~~ a ~~Related~~Material ~~Audit~~Definitive ~~Report or Completed Interim Review~~Agreement.

On ~~March~~April 1310, in2012, ~~the~~Fufeng ~~process~~Jinqiu ofPrinting ~~preparing~~& ~~its~~Packaging ~~annual~~Co., ~~report~~Ltd. ~~on Form 10-K for the year ended December 31~~(“Jinqiu”), ~~2011,~~a ~~management~~subsidiary of ~~the~~China ~~Company~~Printing ~~became~~& ~~aware~~Packaging, ~~that~~Inc. (the “Company’s”), ~~financial~~entered ~~statements~~into ina ~~the~~Paper ~~quarterly~~Products ~~reports~~Research ~~for~~and ~~the~~Development ~~quarters~~Agreement ~~ended~~(“Agreement”) ~~June~~with ~~30,~~Xi’an ~~2011~~Qinling ~~and~~Biotechnology ~~September~~Development 30Co., ~~2011~~Ltd. ~~erroneously~~(“Qinling”). ~~did~~Pursuant ~~not~~to ~~account for~~ the ~~stock~~Agreement, ~~dividend~~Qinglin ~~issued~~will onconduct ~~June~~research ~~15,~~and ~~2011,~~development ~~whereby~~in ~~each~~the ~~stockholder~~areas of ~~record~~entry oninto ~~June~~high-end 15market, ~~2011~~anti-counterfeiting ~~received~~paper, ~~two~~waterproof paper and aproduct ~~half~~design (~~2.5~~“Research Project”). ~~shares~~Jinqiu ofwill ~~common~~pay ~~stock~~an ~~for~~aggregate ~~every~~of ~~one~~Renminbi 8,000,000 as consideration (approximately $1,266,123). ~~share~~Renminbi of7,000,000 ~~common~~(approximately ~~stock~~$1,107,858) ~~which~~is ~~such~~payable ~~stockholder~~within ~~owned.~~15 Ondays ~~March~~of ~~15,~~execution ~~2012,~~of the ~~Company’s~~Agreement ~~Board~~and ofRenminbi ~~Directors~~1,000,000 ~~determined~~(approximately ~~that~~$158,265) ~~the~~is ~~financial~~payable ~~statements~~after ~~included in~~ the ~~quarterly~~Research ~~reports~~Project ~~for~~is ~~the~~completed. ~~quarters~~The ~~ended~~term ~~June~~of ~~30,~~the ~~2011~~Research ~~and~~Project ~~September~~is 30a year, ~~2011~~starting ~~cannot~~from beApril ~~relied~~10, on2012. ~~and~~Upon ~~instructed~~completion of the ~~Company’s~~Research ~~Chief~~Project, ~~Financial~~Qinglin ~~Officer~~will toadvise ~~restate~~Jinqiu ~~such~~on ~~financial~~using ~~statements~~the ~~and~~new ~~file~~printing ~~amendments~~technology todeveloped ~~such~~in ~~financial~~the ~~statements~~Research asProject ~~soon~~for asfive ~~practicable~~years.

The ~~Company’s~~foregoing ~~Board~~description of ~~Directors,~~the asAgreement ~~well~~does asnot ~~its~~purport ~~management~~to ~~have~~be ~~discussed~~complete ~~the~~and ~~matters~~is qualified in ~~this~~its ~~Current~~entirety ~~Report~~by onreference ~~Form~~to ~~8-K~~the ~~with~~full ~~Clement~~text C.of W.such ~~Chan~~agreement &attached ~~Co.,~~to ~~the~~this ~~Company’s~~Form ~~independent~~8-K ~~public~~as ~~registered~~Exhibit ~~accounting~~10.1 ~~firm~~and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

10.1

Paper Products Research and Development Agreement between Fufeng Jinqiu Printing & Packaging Co., Ltd. and Xi’an Qinling Biotechnology Development Co., Ltd., dated April 10, 2012.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CHINA PRINTING & PACKAGING, INC.
Dated: March 19, 2012	By:	/s/ Yongming Feng
Dated: June 6, 2012	By:	/s/ Yongming Feng
	~~Yongming Feng~~	Yongming Feng
	~~Chief Executive Officer~~	Chief Executive Officer

Filing Compare · China Printing & Packaging, Inc.